{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:14:47Z","timestamp":1792826087336,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Affiliated Hospital of Guizhou Medical University","award":["GYFYNSFC-2022-16"],"award-info":[{"award-number":["GYFYNSFC-2022-16"]}]},{"name":"the Affiliated Hospital of Guizhou Medical University","award":["gyfyxkyc-2023-01"],"award-info":[{"award-number":["gyfyxkyc-2023-01"]}]},{"DOI":"10.13039\/501100004001","name":"Guizhou Provincial Science and Technology Department","doi-asserted-by":"crossref","award":["MS[2025]428"],"award-info":[{"award-number":["MS[2025]428"]}],"id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01134-5","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:33:25Z","timestamp":1761662005000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Synergistic blood-based diagnostic value of AP3B1 and BMPR2 in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"11","author":[{"given":"Xiyan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengxiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"1134_CR1","doi-asserted-by":"crossref","unstructured":"Dorsey, E. R., Sherer, T., Okun, M. S. & Bloem, B. R. The emerging evidence of the Parkinson pandemic. J. Parkinson Dis. 8, S3\u2013S8 (2018).","DOI":"10.3233\/JPD-181474"},{"key":"1134_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"1134_CR3","doi-asserted-by":"crossref","unstructured":"Szeg\u0151, \u00c9M. et al. Intermittent fasting reduces alpha-synuclein pathology and functional decline in a mouse model of Parkinson\u2019s disease. Nat. Commun. 16, 4470 (2025).","DOI":"10.1038\/s41467-025-59249-5"},{"key":"1134_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrneurol.2016.200","volume":"13","author":"DH Ffytche","year":"2017","unstructured":"Ffytche, D. H. et al. The psychosis spectrum in Parkinson's disease. Nat. Rev. Neurol. 13, 81\u201395 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"1134_CR5","unstructured":"GBD 2021 ASEAN Injuries Collaborators. The epidemiology and burden of injury in countries of the Association of Southeast Asian Nations (ASEAN), 1990\u20132021: findings from the Global Burden of Disease Study 2021. Lancet Public Health 10, e456\u2013e466 (2025)."},{"key":"1134_CR6","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"1134_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.2967\/jnumed.108.059998","volume":"51","author":"DJ Brooks","year":"2010","unstructured":"Brooks, D. J. Imaging approaches to Parkinson disease. J. Nucl. Med. 51, 596\u2013609 (2010).","journal-title":"J. Nucl. Med."},{"key":"1134_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51502-7","volume":"15","author":"WH Oertel","year":"2024","unstructured":"Oertel, W. H. et al. Acetyl-DL-leucine in two individuals with REM sleep behavior disorder improves symptoms, reverses loss of striatal dopamine-transporter binding and stabilizes pathological metabolic brain pattern \u2013case reports. Nat. Commun. 15, 7619 (2024).","journal-title":"Nat. Commun."},{"key":"1134_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti, L. et al. CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol. 18, 573\u2013586 (2019).","journal-title":"Lancet Neurol."},{"key":"1134_CR10","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky, E. et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N. Engl. J. Med. 361, 1651\u20131661 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1134_CR11","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tins.2021.12.002","volume":"45","author":"EM Rocha","year":"2022","unstructured":"Rocha, E. M. et al. LRRK2 and idiopathic Parkinson\u2019s disease. Trends Neurosci. 45, 224\u2013236 (2022).","journal-title":"Trends Neurosci."},{"key":"1134_CR12","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/mds.28206","volume":"35","author":"B Mollenhauer","year":"2020","unstructured":"Mollenhauer, B. et al. Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression. Mov. Disord. 35, 1999\u20132008 (2020).","journal-title":"Mov. Disord."},{"key":"1134_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2010.06.009","volume":"480","author":"M Shi","year":"2010","unstructured":"Shi, M. et al. Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson\u2019s disease. Neurosci. Lett. 480, 78\u201382 (2010).","journal-title":"Neurosci. Lett."},{"key":"1134_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","volume":"8","author":"P Magalh\u00e3es","year":"2022","unstructured":"Magalh\u00e3es, P. & Lashuel, H. A. Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson\u2019s disease and other synucleinopathies. NPJ Parkinsons Dis. 8, 93 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1134_CR15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-021-02324-0","volume":"142","author":"S Dutta","year":"2021","unstructured":"Dutta, S. et al. \u03b1-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson\u2019s disease from multiple system atrophy. Acta Neuropathol. 142, 495\u2013511 (2021).","journal-title":"Acta Neuropathol."},{"key":"1134_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani, L. et al. Neurofilament light chain as a biomarker in neurological disorders. J. Neurol. Neurosurg. Psychiatry 90, 870\u2013881 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1134_CR17","doi-asserted-by":"publisher","first-page":"e25888","DOI":"10.1097\/MD.0000000000025888","volume":"100","author":"F Kong","year":"2021","unstructured":"Kong, F. et al. RNA-sequencing of peripheral blood circular RNAs in Parkinson disease. Medecine 100, e25888 (2021).","journal-title":"Medecine"},{"key":"1134_CR18","doi-asserted-by":"publisher","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","volume":"2","author":"B Zheng","year":"2010","unstructured":"Zheng, B. et al. PGC-1\u03b1, a potential therapeutic target for early intervention in Parkinson\u2019s disease. Sci. Transl. Med. 2, 52ra73 (2010).","journal-title":"Sci. Transl. Med."},{"key":"1134_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.b.30195","volume":"137B","author":"Y Zhang","year":"2005","unstructured":"Zhang, Y., James, M., Middleton, F. A. & Davis, R. L. Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways and suggests novel disease mechanisms. Am. J. Med. Genet B Neuropsychiatr. Genet 137B, 5\u201316 (2005).","journal-title":"Am. J. Med. Genet B Neuropsychiatr. Genet"},{"key":"1134_CR20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1073\/pnas.0610204104","volume":"104","author":"CR Scherzer","year":"2007","unstructured":"Scherzer, C. R. et al. Molecular markers of early Parkinson\u2019s disease based on gene expression in blood. Proc. Natl. Acad. Sci. USA 104, 955\u2013960 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1134_CR21","doi-asserted-by":"publisher","first-page":"10907","DOI":"10.1073\/pnas.0802437105","volume":"105","author":"CR Scherzer","year":"2008","unstructured":"Scherzer, C. R. et al. GATA transcription factors directly regulate the Parkinson\u2019s disease-linked gene alpha-synuclein. Proc. Natl. Acad. Sci. USA 105, 10907\u201310912 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1134_CR22","doi-asserted-by":"publisher","first-page":"640266","DOI":"10.3389\/fgene.2021.640266","volume":"12","author":"AR Henderson","year":"2021","unstructured":"Henderson, A. R. et al. DNA methylation and expression profiles of whole blood in Parkinson\u2019s disease. Front. Genet. 12, 640266 (2021).","journal-title":"Front. Genet."},{"key":"1134_CR23","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.3390\/cells11162599","volume":"11","author":"EI Semenova","year":"2022","unstructured":"Semenova, E. I. et al. Transcriptome profiling reveals differential expression of circadian behavior genes in peripheral blood of monozygotic twins discordant for Parkinson\u2019s disease. Cells 11, 2599 (2022).","journal-title":"Cells"},{"key":"1134_CR24","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente, E. M. et al. Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304, 1158\u20131160 (2004).","journal-title":"Science"},{"key":"1134_CR25","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy, D. G. et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol. 7, 583\u2013590 (2008).","journal-title":"Lancet Neurol."},{"key":"1134_CR26","doi-asserted-by":"publisher","first-page":"4738","DOI":"10.1074\/jbc.RA118.005008","volume":"294","author":"P Rivero-R\u00edos,","year":"2019","unstructured":"Rivero-R\u00edos, P. et al. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A. J. Biol. Chem. 294, 4738\u20134758 (2019).","journal-title":"J. Biol. Chem."},{"key":"1134_CR27","doi-asserted-by":"publisher","first-page":"104948","DOI":"10.1016\/j.nbd.2020.104948","volume":"141","author":"GR Heaton","year":"2020","unstructured":"Heaton, G. R. et al. Sequential screening nominates the Parkinson\u2019s disease-associated kinase LRRK2 as a regulator of clathrin-mediated endocytosis. Neurobiol. Dis. 141, 104948 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1134_CR28","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/ana.26089","volume":"89","author":"W Singer","year":"2021","unstructured":"Singer, W. et al. Alpha-synuclein oligomers and neurofilament light chain predict phenoconversion of pure autonomic failure. Ann. Neurol. 89, 1212\u20131220 (2021).","journal-title":"Ann. Neurol."},{"key":"1134_CR29","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"1134_CR30","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.4103\/NRR.NRR-D-23-01624","volume":"19","author":"XY Ng","year":"2024","unstructured":"Ng, X. Y. & Cao, M. Dysfunction of synaptic endocytic trafficking in Parkinson\u2019s disease. Neural Regen. Res. 19, 2649\u20132660 (2024).","journal-title":"Neural Regen. Res."},{"key":"1134_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/brain\/awh054","volume":"127","author":"R Bandopadhyay","year":"2004","unstructured":"Bandopadhyay, R. et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson\u2019s disease. Brain 127, 420\u2013430 (2004).","journal-title":"Brain"},{"key":"1134_CR32","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan, Y., Tao, H., He, J. & Huang, S. Y. The HDOCK server for integrated protein-protein docking. Nat. Protoc. 15, 1829\u20131852 (2020).","journal-title":"Nat. Protoc."},{"key":"1134_CR33","doi-asserted-by":"publisher","first-page":"21161","DOI":"10.1073\/pnas.0909176106","volume":"106","author":"C Azevedo","year":"2009","unstructured":"Azevedo, C. et al. Inositol pyrophosphate mediated pyrophosphorylation of AP3B1 regulates HIV-1 Gag release. Proc. Natl. Acad. Sci. USA 106, 21161\u201321166 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1134_CR34","doi-asserted-by":"publisher","first-page":"e3000557","DOI":"10.1371\/journal.pbio.3000557","volume":"17","author":"C Hiepen","year":"2019","unstructured":"Hiepen, C. et al. BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGF\u03b2 responses and altered cell mechanics. PLoS Biol. 17, e3000557 (2019).","journal-title":"PLoS Biol."},{"key":"1134_CR35","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.4103\/1673-5374.274327","volume":"15","author":"SR Goulding","year":"2020","unstructured":"Goulding, S. R., Sullivan, A. M., O\u2019Keeffe, G. W. & Collins, L. M. The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson\u2019s disease. Neural Regen. Res. 15, 1432\u20131436 (2020).","journal-title":"Neural Regen. Res."},{"key":"1134_CR36","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1091\/mbc.E15-08-0547","volume":"27","author":"AR Amsalem","year":"2016","unstructured":"Amsalem, A. R. et al. Differential regulation of translation and endocytosis of alternatively spliced forms of the type II bone morphogenetic protein (BMP) receptor. Mol. Biol. Cell 27, 716\u2013730 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"1134_CR37","doi-asserted-by":"publisher","first-page":"7791","DOI":"10.1128\/MCB.00022-06","volume":"26","author":"A Hartung","year":"2006","unstructured":"Hartung, A. et al. Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling. Mol. Cell Biol. 26, 7791\u20137805 (2006).","journal-title":"Mol. Cell Biol."},{"key":"1134_CR38","doi-asserted-by":"publisher","first-page":"115168","DOI":"10.1016\/j.expneurol.2025.115168","volume":"386","author":"X Tang","year":"2025","unstructured":"Tang, X. et al. Behavioral, biochemical, and molecular characterization of MPTP\/p-intoxicated mice. Exp. Neurol. 386, 115168 (2025).","journal-title":"Exp. Neurol."},{"key":"1134_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02863-0","volume":"22","author":"H Tang","year":"2024","unstructured":"Tang, H. et al. The new advance of exosome-based liquid biopsy for cancer diagnosis. J. Nanobiotechnol. 22, 610 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"1134_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41531-023-00591-0","volume":"9","author":"XJ Gu","year":"2023","unstructured":"Gu, X. J. et al. Expanding causal genes for Parkinson\u2019s disease via multi-omics analysis. NPJ Parkinsons Dis. 9, 146 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1134_CR41","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.bionps.2023.100074","volume":"9","author":"KY Yamashita","year":"2023","unstructured":"Yamashita, K. Y., Bhoopatiraju, S., Silverglate, B. D. & Grossberg, G. T. Biomarkers in Parkinson\u2019s disease: a state of the art review. Biomarkers in Neuropsychiatry 9, 100074 (2023).","journal-title":"Biomarkers in Neuropsychiatry"},{"key":"1134_CR42","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1093\/brain\/awae142","volume":"147","author":"L Cook","year":"2024","unstructured":"Cook, L. et al. Parkinson\u2019s disease variant detection and disclosure: PD GENEration, a North American study. Brain 147, 2668\u20132679 (2024).","journal-title":"Brain"},{"key":"1134_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cpbi.5","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The GeneCards Suite: from gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinforma. 54, 1\u20131 (2016).","journal-title":"Curr. Protoc. Bioinforma."},{"key":"1134_CR44","doi-asserted-by":"publisher","unstructured":"Safran, M. et al. The GeneCards Suite. In: Abugessaisa, I. & Kasukawa, T, (eds) Practical Guide to Life Science Databases. Singapore: Springer; 2022. p. 27\u201356. https:\/\/doi.org\/10.1007\/978-981-16-5812-9_2.","DOI":"10.1007\/978-981-16-5812-9_2"},{"key":"1134_CR45","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki, M. I. et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613, 508\u2013518 (2023).","journal-title":"Nature"},{"key":"1134_CR46","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls, M. A. et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 18, 1091\u20131102 (2019).","journal-title":"Lancet Neurol."},{"key":"1134_CR47","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa, U. et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat. Genet. 53, 1300\u20131310 (2021).","journal-title":"Nat. Genet."},{"key":"1134_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1041-x","volume":"17","author":"E Hannon","year":"2016","unstructured":"Hannon, E. et al. An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation. Genome Biol. 17, 176 (2016).","journal-title":"Genome Biol."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01134-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01134-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01134-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T01:04:12Z","timestamp":1761699852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01134-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1134"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01134-5","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"310"}}